Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Indivior Pharmaceuticals (INDV) Gross Profit (2022 - 2026)

Indivior Pharmaceuticals has reported Gross Profit over the past 5 years, most recently at $277.0 million for Q1 2026.

  • For Q1 2026, Gross Profit rose 25.34% year-over-year to $277.0 million; the TTM value through Mar 2026 reached $1.0 billion, up 12.8%, while the annual FY2025 figure was $994.0 million, 3.87% up from the prior year.
  • Gross Profit for Q1 2026 was $277.0 million at Indivior Pharmaceuticals, down from $292.0 million in the prior quarter.
  • Over five years, Gross Profit peaked at $292.0 million in Q4 2025 and troughed at $183.0 million in Q2 2022.
  • A 5-year average of $231.5 million and a median of $228.0 million in 2023 define the central range for Gross Profit.
  • Biggest five-year swings in Gross Profit: decreased 10.16% in 2025 and later increased 25.34% in 2026.
  • Year by year, Gross Profit stood at $198.0 million in 2022, then rose by 21.72% to $241.0 million in 2023, then increased by 2.9% to $248.0 million in 2024, then increased by 17.74% to $292.0 million in 2025, then dropped by 5.14% to $277.0 million in 2026.
  • Business Quant data shows Gross Profit for INDV at $277.0 million in Q1 2026, $292.0 million in Q4 2025, and $230.0 million in Q3 2025.